Henderson DW - Search Results

1

Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data.

Klebe S, Prabhakaran S, Hocking A, Pulford E, Moore S, Nicola M, Allen PW, Henderson DW. Klebe S, et al. Among authors: henderson dw. Pathology. 2018 Oct;50(6):629-634. doi: 10.1016/j.pathol.2018.06.001. Epub 2018 Aug 28. Pathology. 2018. PMID: 30170702

2

Diagnosis of epithelial mesothelioma using tree-based regression analysis and a minimal panel of antibodies.

Klebe S, Nurminen M, Leigh J, Henderson DW. Klebe S, et al. Among authors: henderson dw. Pathology. 2009 Feb;41(2):140-8. doi: 10.1080/00313020802579250. Pathology. 2009. PMID: 19152187

3

Molecular biomarkers in malignant mesothelioma: state of the art.

Kao SC, Reid G, van Zandwijk N, Henderson DW, Klebe S. Kao SC, et al. Among authors: henderson dw. Pathology. 2011 Apr;43(3):201-12. doi: 10.1097/PAT.0b013e3283445e67. Pathology. 2011. PMID: 21436629 Review.

4

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.

Henderson DW, Reid G, Kao SC, van Zandwijk N, Klebe S. Henderson DW, et al. J Clin Pathol. 2013 Oct;66(10):847-53. doi: 10.1136/jclinpath-2012-201303. Epub 2013 Jun 27. J Clin Pathol. 2013. PMID: 23814259 Review.

5

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.

Henderson DW, Reid G, Kao SC, van Zandwijk N, Klebe S. Henderson DW, et al. J Clin Pathol. 2013 Oct;66(10):854-61. doi: 10.1136/jclinpath-2013-201609. Epub 2013 Jul 6. J Clin Pathol. 2013. PMID: 23833051 Review.

6

An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.

Klebe S, Swalling A, Jonavicius L, Henderson DW. Klebe S, et al. Among authors: henderson dw. J Clin Pathol. 2016 Feb;69(2):136-41. doi: 10.1136/jclinpath-2015-203184. Epub 2015 Aug 17. J Clin Pathol. 2016. PMID: 26281863 Free PMC article.

7

Vasculogenic mimicry in malignant mesothelioma: an experimental and immunohistochemical analysis.

Pulford E, Hocking A, Griggs K, McEvoy J, Bonder C, Henderson DW, Klebe S. Pulford E, et al. Among authors: henderson dw. Pathology. 2016 Dec;48(7):650-659. doi: 10.1016/j.pathol.2016.07.009. Epub 2016 Oct 29. Pathology. 2016. PMID: 27956272 Free article.

8

Malignant mesothelioma in situ: diagnostic and clinical considerations.

Pulford E, Henderson DW, Klebe S. Pulford E, et al. Among authors: henderson dw. Pathology. 2020 Oct;52(6):635-642. doi: 10.1016/j.pathol.2020.06.010. Epub 2020 Aug 20. Pathology. 2020. PMID: 32829890

9

Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.

Klebe S, Mahar A, Henderson DW, Roggli VL. Klebe S, et al. Among authors: henderson dw. Mod Pathol. 2008 Sep;21(9):1084-94. doi: 10.1038/modpathol.2008.125. Epub 2008 Jun 27. Mod Pathol. 2008. PMID: 18587319 Free article.

10

Facts and fiction: premalignant lesions of lung tissues.

Klebe S, Henderson DW. Klebe S, et al. Among authors: henderson dw. Pathology. 2013 Apr;45(3):305-15. doi: 10.1097/PAT.0b013e32835f45fd. Pathology. 2013. PMID: 23448809 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters